<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: To evaluate the impact of <z:mp ids='MP_0002055'>diabetes</z:mp> on outcomes in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and to examine whether this association varies by the location of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (colon vs. rectum) </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: This study includes 4,131 stage I-III <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients, treated between 1995 and 2007 (12.5% diabetic, 53% colon, 47% rectal) in South Korea </plain></SENT>
<SENT sid="2" pm="."><plain>Cox proportional hazards modeling was used to determine the prognostic influence of DM on survival endpoints </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> patients with DM had significantly worse disease-free survival (DFS) [hazard ratio (HR) 1.17, 95% confidence interval (CI): 1.00-1.37] compared with patients without DM </plain></SENT>
<SENT sid="4" pm="."><plain>When considering colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> independently, DM was significantly associated with worse overall survival (OS) (HR: 1.46, 95% CI: 1.11-1.92), DFS (HR: 1.45, 95% CI: 1.15-1.84) and recurrence-free survival (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RFS</z:e>) (HR: 1.32, 95% CI: 0.98-1.76) in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>No association for OS, DFS or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RFS</z:e> was observed in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>There was significant interaction of location of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (colon vs. <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>) with DM on OS (P = 0.009) and DFS (P = 0.007) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: This study suggests that DM negatively impacts survival outcomes of patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> but not <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
</text></document>